His main research concerns Transplantation, Internal medicine, Surgery, Hematopoietic stem cell transplantation and Immunology. His studies deal with areas such as Hematology, Transplantation Conditioning and Haematopoiesis, Stem cell as well as Transplantation. His Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
His Surgery research incorporates elements of Aplastic anemia, Immunosuppression, Cumulative incidence and Cohort. His Hematopoietic stem cell transplantation research is multidisciplinary, incorporating elements of Incidence, Cord blood, Intensive care medicine, Total body irradiation and Autologous stem-cell transplantation. His study in Immunology is interdisciplinary in nature, drawing from both Progenitor cell and Cell.
His primary scientific interests are in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Surgery and Immunology. Jakob Passweg has included themes like Gastroenterology and Oncology in his Internal medicine study. The Transplantation study combines topics in areas such as Leukemia, Acute leukemia and Haematopoiesis, Stem cell.
His Hematopoietic stem cell transplantation study combines topics from a wide range of disciplines, such as Transplantation Conditioning, Incidence, Retrospective cohort study and Hazard ratio. His studies in Surgery integrate themes in fields like Immunosuppression and Anemia. The concepts of his Aplastic anemia study are interwoven with issues in Hematology, Bone marrow failure and Pediatrics.
Jakob Passweg mainly focuses on Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Stem cell. His study looks at the relationship between Internal medicine and fields such as Gastroenterology, as well as how they intersect with chemical problems. Jakob Passweg is studying Graft-versus-host disease, which is a component of Transplantation.
His research in Oncology intersects with topics in Cancer, Chemotherapy, Myeloid, Leukemia and Cohort. The study incorporates disciplines such as Bone marrow failure, Thrombotic microangiopathy, Overall survival, Bone marrow and Multiple myeloma in addition to Hematopoietic stem cell transplantation. His Stem cell research integrates issues from Cancer research and Marrow transplantation.
Jakob Passweg spends much of his time researching Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Gastroenterology. His research links Stem cell with Internal medicine. His Transplantation study incorporates themes from Aplastic anemia, Bone marrow, Hematology and Disease.
His Oncology research includes elements of Hazard ratio, Allogeneic hct, Chronic lymphocytic leukemia, Ibrutinib and Lymphoma. His Hematopoietic stem cell transplantation research incorporates elements of Thrombotic microangiopathy, Respiratory syncytial virus, Immunodeficiency, Survival rate and Complication. His research investigates the link between Gastroenterology and topics such as Myelofibrosis that cross with problems in Incidence, Sibling, Mortality rate, Polycythemia vera and Fibrosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Robert Kralovics;Francesco Passamonti;Andreas S. Buser;Soon Siong Teo.
The New England Journal of Medicine (2005)
Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant Recipients
Hans H Hirsch;Wendy Knowles;Michael Dickenmann;Jakob Passweg.
The New England Journal of Medicine (2002)
Solid Cancers after Bone Marrow Transplantation
Rochelle E. Curtis;Philip A. Rowlings;H. Joachim Deeg;Donna A. Shriner.
The New England Journal of Medicine (1997)
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
G Socié;J V Stone;J R Wingard;D Weisdorf.
The New England Journal of Medicine (1999)
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg;Axel Karow;Ronny Nienhold;Renate Looser.
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.
P. Ljungman;M. Bregni;M. Brune;J. Cornelissen.
Bone Marrow Transplantation (1998)
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
Jakob Passweg;H. Baldomero;P. Bader;Chiara Bonini.
Bone Marrow Transplantation (2016)
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R. Zeiser;A. Burchert;C. Lengerke;M.M. Verbeek.
Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).
Anna Locasciulli;Rosi Oneto;Andrea Bacigalupo;Gerard Socie.
High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
Monique Terwijn;Wim L J van Putten;Angèle Kelder;Vincent H J van der Velden.
Journal of Clinical Oncology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: